Search Results

You are looking at 1 - 10 of 40 items for :

Clear All
Open access

Gordana D. Radosavljevic, Jelena Pantic, Ivan Jovanovic, Miodrag L. Lukic and Nebojsa Arsenijevic

REFERENCES: 1. Liu FT, Rabinovich GA. (2005). Galectins as modulators of tumour progression. Nat Rev Cancer, 5(1), 29-41. 2. Radosavljevic G, Volarevic V, Jovanovic I, Milovanovic M, Pejnovic N, Arsenijevic N, et al. (2012). The roles of Galectin-3 in autoimmunity and tumor progression. Immunol Res, 52,100–110. 3. Moutsatsos IK, Wade M, Schindler M, Wang JL. (1987). Endogenous lectins from cultured cells: nuclear localization of carbohydrate binding protein 35 in proliferating 3T3 fibroblasts. Proc Natl Acad Sci USA, 84, 6452–6456. 4. Yu F

Open access

Olivera Andrejić, Rada Vučić, Svetlana Apostolović, Milan Pavlović, Dragana Stokanović, Valentina Nikolić, Tatjana Jevtović-Stoimenov and Stefan Momčilović

References 1. Lok DJ, Lok SI, Bruggink-Andre de la Porte PW, et al. Galectin 3 is an independent marker for ventricular remodeling and mortality in patients with chronic hart failure. Clin Res Cardiol 2013;102:103-10 https://doi.org/10.1007/s00392-012-0500-y 2. Ho JE, Yin X, Levy D, et al. Galectin 3 and incident atrial fibrillation in the community. Am Heart J.2014;167:729-34 https://doi.org/10.1016/j.ahj.2014.02.009 3. Szadkowska I, Wlazeł RN, Migała M, et al. The association between galectin-3 and occurrence of reinfarction early after

Open access

Jasna Jevdjic, Maja Surbatovic, Snezana Milosavljevic, Goran Rondovic, Ivan Stanojevic, Stevan Eric and Nenad Zornic

References 1. Surbatovic M, Vojvodic D, Khan W. Immune response in critically ill patients. Mediators Inflamm 2018;2018:9524315. 2. Diaz-Alvarez L, Ortega E. The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens. Mediators Inflamm 2017; 2017:9247574. 3. Vasta GR. Galectins as pattern recognition receptors: structure, function and evolution. Adv Exp Med Biol 2012; 946:21-36. 4. Nio-Kobayashi J. Tissue- and cell-specific localization of galectins, beta

Open access

Adrian Lupu, Silvia Lupu and Lucia Agoston-Coldea

preserved ejection fraction. Eur Heart J. 2012 Jul; 33(14):1742-9. DOI: 10.1093/eurheartj/ehs135 8. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004 Feb; 350(7):655-63. DOI: 10.1056/NEJMoa031994 9. Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004 Nov; 110

Open access

Ilija Jeftic, Marina Miletic-Kovacevic, Nemanja Jovicic, Jelena Pantic, Nebojsa Arsenijevic, Miodrag L. Lukic and Nada Pejnovic

recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15:914-20 16. Deiuliis JA, Oghumu S, Duggineni D, Zhong J, Rutsky J, Banerjee A et al. CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance. Obesity (Silver Spring) 2014;22:1264-74 17. Dumic J, Dabelic S and Flӧgel M. Galectin-3: an open-ended story. Biochim Biophys Acta. 2006;1760:616-35 18. Pejnovic N, Pantic J, Jovanovic I, Radosavljevic G, Milovanovic M, Nikolic I, Zdravkovic NS, Djukic AL, Arsenijevic NN, Lukic ML:Galectin-3 deficiency

Open access

Sonia L. Elsharkawy, Wafaa E. AbdEl-Aal, Reham S. E. Esmal, Hanan H. M. Ali, Soheir M. Mahfouz and Ahmed El-Habashi

, Westra WH. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid nodules. Clin Can Rese. 2004;10:2761-2765. 12. Aron M, Kaplia K, Verma K. Utility of galectins-3 expression in thyroid aspirates as a diagnostic marker in differentiating bengin from malignant thyroid neoplasms. Indian J Pathol Microbiol. 2006;49: 376-380. 13. Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G. Diagnostic utility of galectins-3 in aspirates of thyroid follicular lesions. Acta Cytol. 2006; 50: 28-34. 14. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Orlandi

Open access

Nada Pejnovic

REFERENCES 1. Osborn O, Olefsky JM: The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012, 18:363-374. 2. Zhu W, Sano H, Nagai R, Fukuhara K, Miyazaki A, Horiuchi S: The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins. Biochem Biophys Res Commun 2001, 280:1183-1188. 3. Hattasch R, Spethmann S, de Boer RA, Ruifrok WP, Schattke S, Wagner M, Schroeckh S, Durmus T, Schimke I, Sanad W, et al.: Galectin-3 increase in endurance athletes. Eur J

Open access

Žanka Bojić-Trbojević, Nikola Kolundžić, Miloš Petronijević and Ljiljana Vićovac

trophoblast cell to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res 1994; 214: 93-9. Vićovac Lj, Janković M, Čuperlović M. Galectin-1 and -3 in cells of the first trimester placental bed. Hum Reprod 1998; 13: 730-5. Bojić-Trbojević Ž, Janković M, Vićovac Lj. Influence of IGF-I on adhesion, proliferation and galectin-1 production in JAr and JEG-3 choriocarcinoma cell lines. Arch Oncol 2005; 13: 7-11. Cooper DNW. Galectin-1: Secretion and

Open access

Bojana Simovic Markovic, Neda Milosavljevic, Aleksandar Arsenijevic, Marina Gazdic, Miodrag L. Lukic and Vladislav Volarevic

, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012; 2012:718617. 5. Volarevic V, Milovanovic M, Ljujic B, et al. Galectin-3 Deficiency Prevents Concanavalin A- Induced Hepatitis in Mice. Hepatology 2012; 55:1954-1964. 6. Jiang H-R, Al Rasebi Z, Mensah-Brown E, et al. Galectin- 3 Deficiency Reduces the Severity of Experimental Autoimmune Encephalomyelitis. J Immunol 2009; 182:1167-1173. 7. Simovic Markovic B, Nikolic A, Gazdic M, Bojic S, Vucicevic L, Kosic M, Mitrovic S

Open access

Andreea-Luciana Chiotoroiu, Corneliu-Florin Buicu, Claudiu Neagu and Theodora Benedek

and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation . 2016;133:631-638. 4. Wang YC, Yu CC, Chiu FC, et al. Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients. J Card Fail . 2013;19:163-168. 5. Bayes-Genis A, de Antonio M, Vila J, et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. J Am Coll Cardiol . 2014